Net Cash Provided by (Used in) Operating Activities |
-457K |
USD |
+47.1% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
448K |
USD |
|
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-135K |
USD |
-129% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
50M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
3.34M |
shares |
0% |
Q4 2023 |
FY 2023 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-144K |
USD |
+63.9% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
28K |
USD |
-96.8% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Valuation Allowance |
756K |
USD |
+411% |
Q4 2023 |
FY 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Gross |
756K |
USD |
+411% |
Q4 2023 |
FY 2023 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q2 2024 |
Q2 2024 |
Additional Paid in Capital |
205K |
USD |
-84.1% |
Q4 2022 |
FY 2023 |
Share-based Payment Arrangement, Expense |
0 |
USD |
|
Q1 2023 |
Q1 2023 |